Henry Meds vs Mochi Health: Which Is Cheaper in 2026?

Henry Meds vs Mochi Health looks like a simple fight between a flat price and a cheaper-looking per-dose price. When we did the math, it wasn't close. Henry Meds charges one flat monthly price (no membership fee) for compounded semaglutide injections, the same at every dose. Mochi Health charges a monthly membership plus a medication price that climbs with your dose. You'd expect the flat price to win at the top of the dose ladder. It doesn't: Mochi comes out cheaper at every published dose, even against Henry's 12-month prepaid rate. Henry's case rests on other things: no membership to manage, sublingual and oral formats, and a compounded liraglutide option. Mochi adds brand-name medications, insurance help and much deeper support. Here's the full breakdown, with the numbers shown.

Last verified: November 2026 by RxPickr Editorial Team. Prices below come from each provider's own published pages, verified in our November 1, 2026 pricing refresh and spot-checked against the live pages on November 9, 2026. Prices may change. Our methodology is at How we rate providers.

Quick comparison

	Henry Meds	Mochi Health
Pricing model	Flat monthly price, no membership fee	Membership ($79/mo month to month) plus per-dose medication
Compounded semaglutide injection	$297/mo at every dose (less with prepay)	$139/mo at the starting dose to $178/mo at the top dose, membership included
Compounded tirzepatide	Oral tablets only, $349/mo (3-month minimum)	Injection, $169/mo to $278/mo by dose, membership included
Needle-free options	Sublingual semaglutide, oral semaglutide and tirzepatide tablets	Compounded semaglutide pill, FDA-approved Wegovy pill
Brand-name GLP-1s	No	Yes (Wegovy pill, Zepbound, Ozempic and Mounjaro off-label, others listed)
Insurance help	No	Yes, insurance plan with prior authorization filing
Support	Provider evaluation and prescription, no coaching program	Unlimited provider visits, 24/7 care team, health coaches and dietitians on staff
State availability	Not every state; check at signup	Available nationwide per Mochi's FAQ; some medications and pricing vary by state

How the two pricing models work

Henry Meds prices by program, not by dose. Its compounded semaglutide injection program costs $297/month on a month-to-month plan, with no separate membership fee (Henry Meds programs page, November 2026). Henry says the subscription includes a personalized treatment plan, medication and supplies, and shipping (Henry Meds weight management, November 2026). Prepaying cuts the rate: as of November 2026, Henry lists $1,482 for six months (about $247/month) and $2,364 for twelve months (about $197/month). Those prepay rates may change. Your price doesn't move when your dose goes up.

Mochi Health split its compounded pricing by dose in August 2026 (Mochi per-dose pricing announcement). Semaglutide runs from $60 at the 0.22mg weekly starting dose to $99 at 2.67mg. Tirzepatide runs from $90 at 2.2mg to $199 at 16.6mg. On top of that you pay the Health membership: $79/month month to month, or $49/month on a 12-month plan, per Mochi's homepage as of November 2026. New members on the 1-month plan get the first membership month free (Mochi notes the promo isn't available in every state). Mochi also says its medication prices vary by state and pharmacy.

Both providers sell compounded medications. Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before they're sold (FDA). They contain the same active ingredient as Wegovy or Zepbound but are not FDA-approved as finished products. Our compounded vs brand-name semaglutide guide covers that tradeoff in depth.

Compounded semaglutide: the dose-by-dose math

This is the comparison most people searching "Henry Meds vs Mochi" care about. The table uses Mochi's published per-dose prices plus its membership, against Henry's flat rate. All figures are as of November 2026 and may change.

Mochi weekly dose	Mochi total (monthly membership)	Mochi total (12-month membership)	Henry, any dose
0.22mg	$139	$109	$297 month to month
0.44mg	$149	$119	$247 on a 6-month prepay
0.88mg	$161	$131	$197 on a 12-month prepay
1.5mg	$171	$141
2.21mg	$175	$145
2.67mg	$178	$148

Mochi totals are the per-dose medication price plus $79 (monthly membership) or $49 (12-month plan).

Three things jump out.

Mochi is cheaper at the starting dose by a wide margin. At 0.22mg on the month-to-month membership you'd pay $158/month less than Henry's month-to-month price. In your first month on the 1-month plan, if the new-member promo applies in your state (as of November 2026), Mochi's bill is just the medication.

Mochi is still cheaper at the top dose. At 2.67mg, Mochi's month-to-month total of $178 is $119 below Henry's month-to-month price and $19 below Henry's best 12-month prepaid rate. We expected the flat rate to catch up at high doses. On current published prices, it doesn't.

The annual gap is large even in Henry's best case. Take a year on each provider's 12-month plan. Henry's prepay is $2,364. Mochi's 12-month membership is $588, and even if you paid the top-dose $99 every single month, medication would add $1,188, for $1,776 total. That's $588 less than Henry, before counting the cheaper titration months.

One caveat: Mochi's ladder is a set of published list prices, and Mochi says they can vary by state and pharmacy. Confirm your dose price on Mochi's order screen before you commit. For a wider look at low-cost options, see our cheapest semaglutide online roundup.

Tirzepatide: not an apples-to-apples choice

Henry doesn't offer injectable tirzepatide. Its programs page lists compounded tirzepatide only as orally dissolving tablets (Henry Meds programs page, November 2026), at $349/month on a 3-month plan, or about $297/month if you pay the 3-month supply in full (as of November 2026; may change). There's no one-month option.

Mochi sells compounded tirzepatide injections from $169/month at 2.2mg to $278/month at 16.6mg, membership included. So Mochi is cheaper here too, but the bigger difference is the format. The weight-loss evidence for tirzepatide comes from trials of the once-weekly injection, such as SURMOUNT-1, where tirzepatide produced significantly more weight loss than placebo (NEJM, 2022). Oral compounded tirzepatide tablets have not been studied in equivalent clinical trials, and they are not FDA-approved as finished products.

If you want tirzepatide specifically, Mochi is the only one of these two that offers the injectable form. Our cheapest tirzepatide online guide compares it with other providers.

Needle-free options

Henry leans hardest into non-injectable formats. It offers sublingual semaglutide from $179/month (its premium sublingual line; a higher-strength sublingual tablet program is $249/month as of November 2026, may change), oral semaglutide tablets at $249/month on a 3-month plan, and the oral tirzepatide tablets above. It also sells compounded liraglutide, a daily injection, at $179/month.

Mochi offers a once-weekly compounded semaglutide pill from $62/month plus membership ($141 all-in at the starting dose; Mochi doesn't publish higher-dose prices). Mochi can also prescribe the FDA-approved Wegovy pill from $149/month at the starting dose, plus membership. That matters: the Wegovy pill went through FDA review (Novo Nordisk approval announcement), while compounded oral and sublingual semaglutide has not been tested in trials equivalent to those behind the approved products. Mochi's homepage also lists Foundayo (orforglipron), another FDA-approved oral GLP-1 (Lilly approval announcement), but we haven't confirmed its checkout price.

Our GLP-1 without needles guide explains how absorption differs across these formats.

Brand-name medications and insurance

This one is all Mochi. Henry's published programs are cash-pay and compounded only, with no insurance billing or prior authorization help (Henry Meds programs page, November 2026).

Mochi offers an insurance plan from $17/month, in which it checks your coverage and files the prior authorization for brand-name GLP-1s such as Wegovy and Zepbound (Mochi Health, November 2026). Provider visits on that plan run $0 to $30 depending on your copay, per Mochi's homepage as of November 2026 (may change). If your plan covers a brand-name GLP-1, that route may cost less than any compounded option, and you'd be on an FDA-approved product. Our GLP-1 insurance coverage guide walks through how coverage decisions usually work.

Without insurance, Mochi also sells brand-name medications at self-pay prices plus membership: Zepbound from $299/month at 2.5mg, the Wegovy pill from $149/month, and off-label Ozempic from $199/month, each at the starting dose with higher doses costing more. Brand-name semaglutide and tirzepatide were evaluated in large randomized trials (STEP 1 for semaglutide, NEJM, 2021; SURMOUNT-1 for tirzepatide, NEJM, 2022), which compounded versions have not.

Support and oversight

Mochi runs the heavier program. Its Health membership includes unlimited provider visits and a 24/7 care team, and its FAQ describes direct provider messaging, regular video visits with a physician and health coach, and registered dietitians on staff (Mochi FAQ, November 2026). The more intensive dietitian-led nutrition therapy sits in an insurance-backed tier, so check what your plan includes. Lab panels are extra, from $26 per Mochi's homepage as of November 2026 (may change).

Henry keeps things lean: a provider evaluation and prescription, then medication and supplies shipped to your door for one monthly price. Henry's published programs don't include a coaching or nutrition program. For someone who knows what they want and just needs the prescription, that's fine.

Support can matter for side effects. Nausea and other GI effects were the most common adverse events in the semaglutide trials (NEJM, 2021), and the FDA has received reports of adverse events, some requiring hospitalization, that may be related to dosing errors with compounded injectable semaglutide (FDA). If you start a compounded injection with either provider, ask exactly how to measure your dose and who to contact if something feels off. Our GLP-1 side effects guide covers what to expect.

State availability

Henry is not available in every state, and its public FAQ doesn't list which ones it serves (checked November 2026). Check your state during signup before you plan around it. Mochi's FAQ says you can join from anywhere in the United States, though Mochi notes that medication availability and pricing vary by state.

Who should pick which

Pick Mochi Health if:

• You're paying cash for compounded semaglutide and want the lowest bill. On current published prices, Mochi is cheaper at every dose.
• You want injectable tirzepatide.
• You have insurance that might cover Wegovy or Zepbound, or you want the option to move to a brand-name medication later.
• You'd use regular provider visits, coaching or dietitian support.

Pick Henry Meds if:

• You want one flat monthly charge with no membership, no dose-based price changes and nothing to recalculate.
• You specifically want sublingual semaglutide or compounded liraglutide.
• You're in a state Henry serves and value its simpler, low-touch model over the savings.

On the evidence, Mochi is the better value for most self-pay patients and the only real choice for insured patients or anyone who wants tirzepatide injections. Henry's advantages are simplicity and format choice, not price. Whichever you consider, GLP-1 medications require a prescription, so talk through your health history with a licensed clinician before you start.

Still weighing other providers? The RxPickr GLP-1 quiz factors in your budget, insurance, and format preferences.